Imidazopyridine inhibitors of IAP

Details Imidazopyridine inhibitors of IAP Imidazopyridine inhibitors of IAP

2007-12-14

2011-11-22

Fetterolf, Brandon (Department: 1628)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

08063218

ABSTRACT:
The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula I: wherein Q, X1, X2, Y, Z R1, R2, R3, R3′, R4, R4′, R5, R6, R6′ and n are as described herein.

REFERENCES:
patent: 4149003 (1979-04-01), Carlsson et al.
patent: 4278793 (1981-07-01), Durckheimer et al.
patent: 4720484 (1988-01-01), Vincent et al.
patent: 4837165 (1989-06-01), Hawke
patent: 4935494 (1990-06-01), Miller
patent: 5411942 (1995-05-01), Widmer et al.
patent: 5559209 (1996-09-01), Nishimoto
patent: 6472172 (2002-10-01), Deng et al.
patent: 6608026 (2003-08-01), Wang et al.
patent: 6992063 (2006-01-01), Shi
patent: 7041784 (2006-05-01), Wang et al.
patent: 7067274 (2006-06-01), Fairbrother
patent: 7244851 (2007-07-01), Cohen et al.
patent: 2002/0177557 (2002-11-01), Shi
patent: 2003/0157522 (2003-08-01), Boudreault et al.
patent: 2004/0171554 (2004-09-01), Franklin et al.
patent: 2005/0197403 (2005-09-01), Harran et al.
patent: 2005/0214802 (2005-09-01), Fairbrother et al.
patent: 2005/0234042 (2005-10-01), Palermo et al.
patent: 2006/0052311 (2006-03-01), Sharma et al.
patent: 2006/0167066 (2006-07-01), Cohen et al.
patent: 92/01938 (1992-02-01), None
patent: 94/11026 (1994-05-01), None
patent: 00/00823 (2000-01-01), None
patent: 00/39585 (2000-07-01), None
patent: 02/16402 (2002-02-01), None
patent: 02/16418 (2002-02-01), None
patent: 02/26775 (2002-04-01), None
patent: 02/30959 (2002-04-01), None
patent: 02/096930 (2002-12-01), None
patent: 03/010184 (2003-02-01), None
patent: 03/086470 (2003-10-01), None
patent: 2004/005248 (2004-01-01), None
patent: 2004/007529 (2004-01-01), None
patent: 2004/017991 (2004-03-01), None
patent: 2004/072641 (2004-08-01), None
patent: 2004/106371 (2004-12-01), None
patent: 2005/049853 (2005-06-01), None
patent: 2005/097791 (2005-10-01), None
patent: 2006/020060 (2006-02-01), None
patent: 2006/091972 (2006-08-01), None
Lawton et al. J. Org. Chem, 1999, 64, 5329-5332.
Arnt et al., “Synthetic Smac/DIABLO Peptides Enhance the Effects of Chemotherapeutic Agents by Binding XIAP and cIAP1 in Situ”J. Bio. Chem. 277(46):44236-44243 (Nov. 2002).
Baktiar, et al., “Transfer of alkoxycarbonyl from alkyl imidazolium-2-carboxylates to benzyl alcohol, a cyclohexanone enamine and diethylamine”J. Chem. Soc. Perkin Trans. 13:329-243 (Jan. 1994).
Blass, B.E. et al., “Parallel Synthesis and Evaluation of N-(1-Phenylethyl)-5-phenyl-imidazole-2-amines as Na+/K+ ATPase inhibitors”Bioorg. Med. Chem. Lett. 10:1543-1545 (2000).
Boatright et al., “A Unified Model for Apical Caspase Activation”Molecular Cell11:529-541 (2003).
Chai Jijie et al., “Structural and biochemical basis of apoptotic activation by SMAC/Diablo”Nature, London, GB:Nature Publishing Group vol. 406(6798):855-862 (Aug. 24, 2000).
Chari et al., “Immunoconjugates Containing Novel Maytansinoids: Promising Anticancer Drugs”Cancer Research52:127-131 (Jan. 1992).
Chen et al., “grim, a novel cell death gene inDrosophila” Genes&Development10:1773-1782 (1996).
Christich et al., “The Damage-ResponsiveDrosophilaGene sickle Encodes a Novel IAP Binding Protein Similar to but Distinct from reaper, grim, and hid”Current Biology12:137-140 (2002).
Corey, E.J. et al., “(+)-1(S), 5(R), 8(S)-phenyl-2-azabicyclo[3.3.0]OCTAN-8-0L N, O-methylboronate (2) and its enantiomer, chiral chemzymes which serve as catalysts for their own enantioselective synthesis”Tetrahedron Letters30(41):5547-5550 (1989).
Crook et al., “An Apoptosis-Inhibiting Baculovirus Gene with a Zinc Finger-Like Motif”Journal of Virology67(4):2168-2174 (Apr. 1993).
Derossi et al., “Trojan Peptides: The Penetratin System for Intracellular Delivery”Trends Cell Biol. 8:84-87 (Feb. 1998).
Deveraux et al., “Endogenous Inhibitors of Caspases”J. Clin. Immunol. 19(6):388-398 (1999).
Deveraux et al., “IAPs Block Apoptotic Events Induced by Caspase-8 and Cytochrome c by Direct Inhibition of Distinct Caspases”EMBO Journal17(8):2215-2223 (1998).
Deveraux, Q. & Reed, J., “IAP family proteins-suppressors of apoptosis”Genes Dev13:239-252 (1999).
Duckett et al., “A Conserved Family of Cellular Genes Related to the Baculovirus iap Gene and Encoding Apoptosis Inhibitors”EMBO Journal15(11):2685-2694 (1996).
Fong et al., “Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines”Genomics70:113-122 (2000).
Franklin et al., “Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (ML-IAP)”Biochemistry42:8223-8231 (2003).
Fulda et al., “Smac Agonists Sensitize for Apo2L/TRAIL- or Anticancer Drug-Induced Apoptosis and Induce Regression of Malignant Glioma in Vivo”Nature Medicine8(8):808-815 (Aug. 2002).
Goyal et al., “Induction of apoptosis byDrosophilareaper, hid and grim through inhibition of IAP function”Embo Journal19:589-597 (2000).
Grether et al., “The head involution defective gene ofDrosophila melanogasterfunctions in programmed cell death”Genes Dev9:1694-1708 (1995).
Guo et al., “Ectopic Overexpression of Second Mitochondria-Derived Activator of Caspases (Smac/DIABLO) or Cotreatment with N-Terminus of Smac/DIABLO Peptide Potentiates Epothilone B Derivative-(BMS 247550) and Apo-2L/TRAIL-Induced Apoptosis”Blood99:3419-3426 (2002).
Hinds et al., “Solution Structure of a Baculoviral Inhibitor of Apoptosis (IAP) Repeat”Nat. Struct. Biol. 6:648-651 (Jul. 1999).
Hu et al., “Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo”Clin. Cancer Res9(7):2826-2836 (2003).
Jones et al., “Improved methods for building protein models in electron density maps and the location of errors in these models”Acta Cryst. A47:110-119 (1991).
Keating et al., “Putting the Pieces Together: Contribution of Fluorescence Polarization Assays to Small Molecule Lead Optimization”Proceedings of SPIE: In Vitro Diagnostic Instrument., Cohn, G.E. ed. vol. 3913:128-137 (2000).
Kipp et al., “Molecular Targeting of Inhibitor of Apoptosis Proteins Based on Small Molecule Mimics of Natural Binding Partners.”Biochemistry41:7344-7349 (2002).
Kolb et al., “Use of a novel homogeneous fluorescent technology in high throughput screening”J Biomolecular Screening1(4):203-210 (1996).
Kolb et al., “Use of a Novel Homogeneous Fluorescent Technology in High Throughput Screening”J. Biomol. Screening1(4):203-210 (1996).
LaCasse et al., “The inhibitors of apoptosis (IAPs) and their emerging role in cancer”Oncogene17(25):3247-3259 (1998).
Lawton, et al., “A Bioactive Modified Peptide, Aeruginosamide, Isolated from the Cyanbacterium Microcytis aeruginosa”J. Org. Chem. 64:5329-5332 (Jun. 24, 1999).
Lin et al., “Resistance of bone marrow-derived macrophages to apoptosis is associated with the expression of X-linked inhibitor of apoptosis protein in primary cultures of bone marrow cells”Biochemical Journal353:299-306 (2001).
Lin, Li et al., “A small molecule Smac mimic potentiates TRAIL- and TNF alpha-mediated cell death”Science305:1471-1474 (2004).
Liston et al., “Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes”Nature379:349-353 (1996).
Liu et al., “Eradication of Large Colon Tumor Xenografts by Targeted Delivery of Maytansinoids.”Proc. Natl. Acad. Sci. USA93:8618-8623 (1996).
Liu et al., “Structural Basis for Binding of Smac/DIABLO to the XIAP BIR3 Domain”Nature408:1004-1008 (Dec. 2000).
Masuda et al., “Studies on mesoionic compounds. Part 11. Alkylation of 5-acylamino-1,2,3-thiadiazoles”J. Chem. Soc. Perkin. Trans. 15:1591-1595 (1981).
Murray , D. et al.

Affiliated with

Also associated with

Rating

Imidazopyridine inhibitors of IAP does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazopyridine inhibitors of IAP, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridine inhibitors of IAP will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4291310